Format

Send to

Choose Destination
Clin Infect Dis. 2005 May 15;40(10):e84-6. Epub 2005 Apr 13.

Escherichia coli: development of carbapenem resistance during therapy.

Author information

1
Hackensack University Medical Center, Hackensack, NJ 07601, USA. thong@humed.com

Abstract

A 76-year-old woman had recurrent urosepsis due to extended-spectrum beta -lactamase-positive Escherichia coli. Imipenem resistance was detected after long-term imipenem-meropenem therapy. The carbapenem-hydrolyzing enzyme gene was identified as blaKPC-3. To our knowledge, this is the first documented case in which carbapenem-resistant E. coli emerged during therapy with imipenem and meropenem, and the first identification of the carbapenem-hydrolyzing enzyme in E. coli isolates.

PMID:
15844056
DOI:
10.1086/429822
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center